Triptorelin pamoate

Triptorelin pamoate is used to treat advanced prostate cancer by suppressing testosterone production. It’s also prescribed for endometriosis and uterine fibroids to lower estrogen levels. In children, it treats central precocious puberty by delaying early hormonal development. As a long-acting GnRH agonist, it offers sustained hormone suppression through depot injections. It is grouped under the following drug class(es): Antineoplastic agents, LHRH analogues and Peptides. Its therapeutic use is listed as antineoplastics. The directory classifies it as a commercial API with a peptide source/manufacturing origin. Other names for this substance include Decapeptyl, Triptorelin Embonate and Trelstar. Its PubChem CID is 25074469.

CAS No 124508-66-3
Molecular Formula C87H98N18O19
Molecular Weight 1699.8 g/mol
Synonyms (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(2-amino-2-oxoethyl)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide;4-[(3-carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic acid

Frequently Asked Questions